What companies are LABD's competitors?

Direxion Daily S&P Biotech Bear 3X ETF (LABD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does LABD compare to its peers?

The peer comparison table on this page shows Direxion Daily S&P Biotech Bear 3X ETF (LABD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does LABD operate in?

Direxion Daily S&P Biotech Bear 3X ETF (LABD) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

LABD

Direxion Daily S&P Biotech Bear 3X ETF

AMEX·Asset Management, Leveraged · Financial Services

$7.25$0.18−2.42%

Pre-market·$7.39+1.96%

Market cap$16.57M·Market closed·Sep 14 8:00 PM UTC

Frequently Asked Questions About LABD

What companies are LABD's competitors?: Direxion Daily S&P Biotech Bear 3X ETF (LABD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does LABD compare to its peers?: The peer comparison table on this page shows Direxion Daily S&P Biotech Bear 3X ETF (LABD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does LABD operate in?: Direxion Daily S&P Biotech Bear 3X ETF (LABD) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

LABD

Direxion Daily S&P Biotech Bear 3X ETF

AMEX·Asset Management, Leveraged · Financial Services

$7.25$0.18−2.42%

Pre-market·$7.39+1.96%

Market cap$16.57M·Market closed·Sep 14 8:00 PM UTC

Peers


GLL	ProShares - UltraShort Gold	$23.60	$110.6M
BITI	ProShares Short Bitcoin ETF	$19.02	$96.2M
DIG	ProShares - Ultra Energy	$74.08	$77.7M
SARK	Tradr 1X Short Innovation Daily ETF	$25.49	$64.2M
TSLS	Direxion Daily TSLA Bear 1X ETF	$56.64	$55.7M
INDL	Direxion Daily MSCI India Bull 2X ETF	$42.44	$54.6M
MAGX	Roundhill Daily 2X Long Magnificent Seven ETF	$58.27	$52.7M
DRN	Direxion Daily Real Estate Bull 3X ETF	$9.80	$40.4M
DRIP	Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF	$31.15	$32.5M
JDST	Direxion Daily Junior Gold Miners Index Bear 2X ETF	$23.79	$23.9M

Frequently Asked Questions About LABD

What companies are LABD's competitors?: Direxion Daily S&P Biotech Bear 3X ETF (LABD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does LABD compare to its peers?: The peer comparison table on this page shows Direxion Daily S&P Biotech Bear 3X ETF (LABD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does LABD operate in?: Direxion Daily S&P Biotech Bear 3X ETF (LABD) operates in the Asset Management - Leveraged industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.